Cambridge-led SARS-CoV-2 genomic surveillance consortium receives £12.2 million

November 18, 2020

The viral genome sequencing data will be integrated within the four UK Public Health Agencies & NHS Test and Trace to help understand outbreaks and strengthen infection control measures. Viral genome sequencing also enables monitoring of the evolution of the virus for mutations that may impact on the efficacy of vaccines. The COVID-19 pandemic, caused by the SARS-CoV-2 virus, represents a major threat to health. The COG-UK Consortium was created to deliver large-scale and rapid whole-genome virus sequencing to local NHS centres, Public Health Agencies and the UK government. This will help establish a comprehensive national dataset linking viral sequencing with host genomics, immunology, clinical outcomes and risk factors.

The source of this news is from University of Cambridge